全球生命科学
概述
Featured News & Insights
0017
Contacts
Services
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we can offer you a holistic legal approach that will smooth your path as you navigate industry changes, technological advances, market demands and policy hurdles.
Regions
From high-profile transactions to regulatory issues and complex litigation, we collaborate across borders and disciplines to help our clients in more than 70 countries face challenges and embrace opportunities.

All Professionals
sort
Capabilities
Related Resources
Related Blogs
News & Insights
Bay Area Life Sciences RoundtableWednesday, July 22, 2026Sidley Shortlisted in 16 Categories at the LMG Life Sciences Americas Awards 2026July 20, 2026Sidley Represents Sino Biopharm in an Exclusive License Agreement With AstraZenecaJuly 13, 2026OIG Signals Further Support for Manufacturer-Sponsored Testing Programs with Fourth Favorable Advisory OpinionJuly 8, 2026
活动
荣誉
公告
Global Life Sciences Update
OIG Signals Further Support for Manufacturer-Sponsored Testing Programs with Fourth Favorable Advisory OpinionJuly 8, 2026U.S. Clinical Trials: Federal Government Considers Safe Harbors to Encourage Enrollment and RetentionJuly 7, 2026Corporate Practice of Medicine Update: California Attorney General Announces Carbon Health SettlementJuly 6, 2026A New Era for Agricultural Subsidies: Commerce Opens Door to Countervailing Broad Farm SubsidiesJune 18, 2026
Global Life Sciences Update
Global Life Sciences Update
Healthcare Update
Global Arbitration, Trade and Advocacy Update
DOJ’s Civil Rights Fraud Initiative Raises False Claims Act Risks for Healthcare and Life Sciences CompaniesJune 4, 2026Securities Class Actions in the Life Sciences SectorSpring 2026Congress Passes Significant Federal Pharmacy Benefit Manager Reform Impacting Pharmaceutical Market AccessApril 9, 2026FDA's Crackdown On Drug Ads Conflicts With PrecedentApril 2, 2026
Reuters
出版专著
Westlaw Today
Law360
Sidley Represents Sino Biopharm in an Exclusive License Agreement With AstraZenecaJuly 13, 2026Sidley Adds Mayan Katz to Emerging Companies and Venture Capital and Global Life Sciences Practices in New YorkJuly 8, 2026Sidley Secures Landmark Victory Rejecting Industry-Wide Liability in First-of-Its-Kind Ultra-Processed Foods LitigationJuly 6, 2026盛德助力和誉医药与礼来公司达成19亿美元战略合作July 2, 2026
公告
新闻稿
公告
公告
Sidley Shortlisted in 16 Categories at the LMG Life Sciences Americas Awards 2026July 20, 2026Sidley Highly Ranked in Chambers USA 2026June 4, 2026Sidley Wins Seven “Firm of the Year” Recognitions at the China Business Law AwardsMay 29, 2026Sidley Wins Three Awards at the Managing IP Americas Awards 2026April 10, 2026
荣誉
荣誉
荣誉
荣誉
AI Collaborations – From Strategic License to Strategic AcquisitionJune 15, 2026The EU AI Act’s Machinery Exemption: Does It Extend to Surgical Robotics?June 11, 2026Most-Favored-Nations Drug Pricing Policy: White House Quietly Releases Report Describing Voluntary MFN DealsMay 29, 2026FDA’s Elsa at Eleven Months: AI-Powered Operations and One-Day Inspections Signal a New Oversight ParadigmMay 20, 2026
GoodLifeSci
GoodLifeSci
GoodLifeSci
GoodLifeSci









































